Fungal infection (FI) after allogeneic hematopoietic cell transplantation (HCT) is associated
with increased morbidity and mortality. Neutropenia, HLA mismatch, graft-versus-host …

Objectives T‐cell–replete haploidentical stem cell transplantation (Haplo‐SCT) with post‐
transplant cyclophosphamide (PT‐Cy) is at high risk of invasive fungal infections (IFI), and …

Diagnosis, management, and prevention of invasive fungal inf... : Current Opinion in Organ
Transplantation Diagnosis, management, and prevention of invasive fungal infections in …

Background Invasive fungal infections (IFI s) are a major cause of mortality among
allogeneic hematopoietic stem cell transplantation (allo‐HSCT) patients. Thanks to the …

Allogeneic hematopoietic cell transplant (HCT) recipients are at increased risk of invasive
fungal infections (IFI), which are associated with a high mortality rate. We evaluated the …

Hematopoietic cell transplantation (HCT) offers definitive management for a wide variety of
malignant and nonmalignant diseases. Conditioning regimens and therapies used to …

Background Invasive fungal infections (IFI) represent a common side effect of allogeneic
hematopoietic stem cell transplant (allo‐SCT), resulting in increased non relapse mortality …

We evaluated the potential correlation of the hematopoietic cell transplantation comorbidity
index (HCT-CI) with the risk of developing post-transplant invasive fungal infections (IFIs) …

Post-transplantation cyclophosphamide (PTCy) is an effective strategy for graft-versus-host
disease (GVHD) prophylaxis and is the standard of care for haploidentical hematopoietic …

Patients who develop severe graft-versus-host disease (GvHD) after allogeneic stem cell
transplantation (alloSCT) have a higher risk for invasive fungal infection (IFI). At our center …